Clathrin-mediated endocytosis occurs at multiple independent import sites on the plasma membrane, but how these positions are selected and how different cargo is simultaneously recognized is obscure. FCHO1 and FCHO2 are early-arriving proteins at surface clathrin assemblies and are speculated to act as compulsory coat nucleators, preceding the core clathrin adaptor AP-2. Here, we show that the µ-homology domain of FCHO1/2 represents an endocytic interaction hub. Translational silencing of fcho1 in zebrafish embryos causes strong dorsoventral patterning defects analogous to Bmp signal failure. The Fcho1 µ-homology domain interacts with the Bmp receptor Alk8, uncovering an endocytic component that positively modulates Bmp signal transmission. Still, the fcho1 morphant phenotype is distinct from severe embryonic defects apparent when AP-2 is depleted. Our data thus challenge the primacy of FCHO1/2 in coat initiation.
1 (FCHO1) and FCHO2 were proposed to be functionally redundant founder proteins demarcating sites of future clathrin assembly 12 . Here, we examine the endocytic activity of the modular FCHO1 and FCHO2 proteins to address the following questions. What molecular interactions distinguish the various protein domains? What role do Fcho1 and Fcho2 play in zebrafish embryonic development? Are Fcho1 and Fcho2 functionally interchangeable? And, if FCHO1/2 is obligatory for clathrin-coat nucleation, does the phenotype of Fcho1/2-compromised embryos parallel that of AP-2 morphants? We find Fcho1 operates during dorsoventral patterning of the embryo and associates with activin receptor-like kinase 8 (Alk8, also known as Acvr1l and Lost-a-fin), a type I BMP receptor involved in signalling ventral-cell fates 13, 14 . Yet AP-2 depletion causes a much more penetrant, broadly severe and earlier developmental phenotype, indicating that AP-2 function is not dependent on Fcho1/2.
RESULTS

FCHO1
and FCHO2 are members of the muniscin subfamily of EFC (or F-BAR) domain proteins, evolutionarily conserved from unicellular eukaryotes to mammals 15, 16 . These paralogues play a functionally redundant role beginning at the earliest assembly stages of clathrinmediated endocytosis 7, 12, 15, 17, 18 . HeLa cells express transcripts for both FCHO1 and FCHO2, but endogenous FCHO1 protein is undetectable Transferrin Transferrin * * * S P S P S P S P S P S P S P S P S P S P S P S P GST-eps15
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Hrb CALM SHIP2 S P S P S P S P S P S P S P * * with antibodies 19 . Transient expression of green fluorescent protein (GFP)-tagged FCHO1 reveals scattered bright puncta on the ventral surface, but a diffuse membrane-tethered population becomes evident with higher overexpression (Supplementary Fig. S1a ). The heterogeneously sized fluorescent structures in cells expressing low-level GFP-FCHO1 co-localize with AP-2 but are spatially distinct from peripheral APPL1-positive endosomes or more centrally positioned EEA1-positive endosomes (Supplementary Fig. S1b-e (∼75%) overlap, although not perfect coincidence, with AP-2 ( Supplementary Fig. S1f-i ). These findings confirm that FCHO1/2 operate at clathrin-coated structures at the cell surface.
The FCHO endocytic hub
FCHO1 and FCHO2 are modular proteins ( Supplementary Fig. S1j ).
The amino-terminal EFC domain is connected to a ∼280-residue carboxy-terminal µ-homology domain (µHD) by linkers of differing length in the paralogues. The first 270 residues of human FCHO1 and FCHO2, encoding a helical EFC-domain monomer 21 , are 58% identical. Accordingly, dose-dependent association of purified FCHO1 EFC domain with PtdIns(4,5)P 2 -containing liposomes parallels that of FCHO2 (Supplementary Fig. S1k ; refs 12,21) . Binding to liposomes lacking PtdIns(4,5)P 2 is ∼10-fold less efficient. The membrane-binding and curvature-sensing/inducing properties 21 of the antiparallel EFCdomain dimer in FCHO1 and FCHO2 are thus similar. Protein-disorder predictions indicate that the EFC-and µHD-separating residues (300-600) of FCHO1 comprise a lowcomplexity, largely unstructured segment. Intrinsic disorder is a hallmark of numerous endocytic factors that bind AP-2 using short, tandemly arrayed peptide motifs in the flexible region 5, 8, 22 . Glutathione S-transferase (GST)-fusion proteins encompassing the central portion of FCHO1 engage AP-2 in pulldown assays (Fig. 1a,b) . The apparent affinity of this association with AP-2 is weaker than that of the C-terminal segment of ARH (autosomal recessive hypercholesterolaemia), which engages AP-2 with a K D of ∼1 µM (refs 23,24) . The main AP-2 interaction determinant(s) in FCHO1 is between residues 267 and 442 (Fig. 1a,b) . Unlike ARH, the central segment of FCHO1 does not bind clathrin directly (Fig. 1b) . FCHO2 does not associate with AP-2 ( Supplementary Fig. S2a) ; the shorter central linker in FCHO2 shows less than 30% identity with FCHO1, probably explaining the absence of AP-2 interaction motif(s).
FCHO1 binds AP-2 through the globular appendage domain of the large α subunit, but some association with the β2-subunit appendage is also evident (Fig. 1c) . The contact site on the α appendage is the platform subdomain, because a W840A substitution abolishes binding (Fig. 1d) ; a sandwich subdomain disruption (Q782A; refs 25,26) has no effect on binding. Yet RNA interference suppression of AP-2, causing pronounced accumulation of dispersed transferrin receptors at the cell surface 27, 28 , is still compatible with surface-clustered FCHO1 or 2 puncta (Fig. 1e-l ) also containing clathrin (Fig. 1m ) and eps15 ( Supplementary Fig. S2b ), in line with these proteins being constituents of a pioneer unit 7, 12, 17 . AP-2 depletion is seen on immunoblots (Fig. 1n) . Thus, despite binding AP-2, the heterotetramer is not necessary for FCHO1 (or FCHO2) surface puncta. This is consistent with FCHO2 not contacting AP-2 directly and also supported by truncation analysis; whereas full-length GFP-FCHO1(1-889) masses at AP-2 patches, GFP-FCHO1(1-275) and (1-609) are diffusely plasma-membrane associated ( Fig. 1o-q) and GFP-FCHO1(265-467) and (265-609) are cytosolic ( Supplementary Fig. S2 ). By contrast, GFP-µHD(609-889) populates clathrin spots, albeit not as efficiently as the full-length protein (Fig. 1r ). Precise deposition of FCHO1 at clathrin foci therefore depends, in part, on the C-terminal µHD.
The muniscins associate with eps15 (refs 12,15,29) . Reciprocalpulldown assays using a GST fusion with the C terminus of eps15(595-896) confirm that binding requires the µHD (Fig. 2a) . µHDs also associate with intersectin 1 (Fig. 2b) , another EH (and SH3)-domain scaffold protein involved in clathrin-mediated endocytosis 30, 31 that hetero-oligomerizes with eps15 (ref. 32 ). Yet, unlike the AP-2 α-subunit appendage, which also binds eps15 and intersectin to a similar extent, the µHDs do not interact with endocytic factors such as AP180, amphiphysin or epsin 1. The capacity of FCHO1/2 to associate with membranes in a PtdIns(4,5)P 2 -dependent manner and engage AP-2 and other core endocytic components (eps15, intersectin) distinguishes these proteins as dedicated endocytic factors. This is consistent with positioning of FCHO1/2 at clathrin structures on the plasma membrane (Fig. 1) .
The FCHO1/2 µHDs also associate with eps15, eps15R and intersectin in HeLa lysates. In addition, Dab2, Hrb and CALM, three tandem Asn-Pro-Phe-containing CLASPs, bind the µHDs in a concentration-dependent manner (Fig. 2c ). Three observations rule out that these associations are indirect and mediated by Asn-Pro-Phe sequences binding to the EH-domain scaffolds (eps15/R and intersectin). First, Dab2, Hrb and CALM binding does not parallel binding of the EH-domain proteins to GST-µHDs. Second, Hrb and CALM bind efficiently to only the FCHO1 µHD and neither FCHO2 nor SGIP1, despite all exhibiting robust eps15 and intersectin interactions. Third, preincubating HeLa lysates with GST-FCHO2 µHD removes the majority of eps15 and intersectin, but remaining Hrb and CALM engage GST-FCHO1 µHD in second-stage incubations indistinguishably from GST-preincubated lysate (Fig. 2d ). This reveals that association of Dab2, Hrb and CALM with the FCHO1 µHD is independent of EH-domain proteins and highlights a functional difference between FCHO1 and FCHO2/SGIP1 µHDs.
The Asp-Pro-Phe tripeptide-rich C terminus of eps15 was used to delineate the FCHO1 µHD-binding region (Fig. 2e,f) . A limited tract positioned between eps15 residues ∼600 and 660 is recognized by the µHD. As this short eps15(595-660) peptide efficiently competes with cytosolic Hrb, CALM and Dab2 in assays at lower concentrations than required to displace eps15R, intersectin or eps15 (Fig. 2g) , all probably engage the FCHO1 µHD through a common or partly overlapping interaction surface, but with the scaffolds binding with higher apparent affinity. Numerous important accessory proteins and CLASPs thus converge on the FCHO1 µHD ( Fig. 2h ) and, therefore, similarly to the AP-2 appendage domains 6, 8 , this domain represents an endocytic hub.
FCHO1 affects embryogenesis
Misexpression of mammalian FCHO1 in zebrafish confirms the µHD importance. On microinjecting synthetic GFP-FCHO1(1-889) messenger RNA into one-cell-stage embryos, fluorescence is visible during the early gastrula period, ∼5 h post fertilization (hpf; Fig. 3a ). Co-injection of a membrane-tethered red fluorescent protein (RFP) marker shows GFP-FCHO1 concentrates at the blastomere plasma membrane, but in discontinuous puncta as opposed to the uninterrupted RFP. The punctate GFP-FCHO1 pattern overlaps with endogenous AP-2 ( Fig. 3b,c) . By 24 hpf, microinjected ectopic mammalian FCHO1 produces a gain-of-function phenotype. Unlike controls, the FCHO1-expressing embryos are cyclopic and mildly ventralized, with small head regions, misshapen trunk somites, and loss of notochord tissue in severely affected embryos ( Fig. 3d-j) . Comparative in situ localization of transcripts for dorsally specified axial mesoderm, no tail and sonic hedgehog, confirms disruption of dorsal patterning. Strikingly, misexpression of similar amounts of a µHD-truncated FCHO1(1-609; µHD) mRNA leads to strong dorsalization (Fig. 3j,k) . Embryos now show posteriorly shortened and twisted body axes and loss of the yolk extension and tail. The most severe resemble C4/C5 category snailhouse (bmp7 ) and swirl (bmp2b) mutant embryos 33, 34 . Injection of FCHO1 µHD(609-889) mRNA alone phenocopies FCHO1(1-609) overexpression (Fig. 3j,l) , indicating that the dominant-negative effect derives from uncoupling the linked domains and that the normal operation of FCHO1 requires physical connection of the EFC and µHD regions. These reciprocal dysmorphic effects suggest that muniscins participate in early embryogenesis. In fact, because dorsoventral patterning is governed in part by Bmp signalling 35 , Fcho1 may assist operation of Bmp receptors during gastrulation. The Smad1/5/8 transcription factors are direct phosphotargets of the type I Bmp receptor Alk8 (ref. 36) , and phosphoSmad (pSmad1/5/8) localization is grossly misplaced dorsally in constitutively active (CA * ) alk8 mRNA-injected embryos (Fig. 3m,n) . Likewise, ectopic FCHO1 expression drives notable, but weaker, dorsal expansion of nuclear pSmad1/5/8 localization in gastrulas ( Fig. 3o-s GST-µHDs S P S P S P S P S P S P S P 68 43 30 GST 
Danio rerio Fcho1 and Fcho2 in dorsoventral patterning
A single gene encodes Fcho1 (LOC565812) and Fcho2 (ZDB-GENE-050522-228) in zebrafish. The structural and topological features are conserved in the teleost proteins ( Supplementary Fig. S3 ) and maternally deposited transcripts for both Fcho1 and Fcho2 are present; PCR with reverse transcription (RT-PCR) confirms the presence of the appropriate gene-specific amplicons whereas in situ hybridization shows localization in four-cell embryos through shield stage (when gastrulation begins) at ∼6 hpf ( Supplementary Fig. S3 ). After the onset of general zygotic transcription (∼3 hpf), both fcho1 and fcho2 transcripts are still detectable and increase gradually through the segmentation period to 24 hpf. Both fcho1 and fcho2 messages are broadly distributed but, by 24 hpf, regional differences are apparent; expression patterns are therefore overlapping but not identical.
Injecting an initiation-codon-targeting fcho1 antisense morpholino oligonucleotide ( Supplementary Fig. S4 ) at the one-cell stage causes a strong dorsalized phenotype at 24 hpf, where structures originating from the dorsal side predominate, with accompanying loss of ventral tissues (Fig. 4a-g ). Again, severely affected embryos mirror snailhouse and swirl mutants. The phenotype is dose dependent, with increased lethality at higher morpholino oligonucleotide concentrations. Morpholino oligonucleotide efficacy is verified by silencing of an appropriate fcho1-GFP reporter ( Supplementary Fig. S4 ) and the phenotype is not markedly different in p53 morpholino oligonucleotide-co-injected embryos 37 . Earlier in development, at the end of gastrulation (∼10 hpf), the fcho1 morphants are oblong (Fig. 4h,i) , typical of dorsalization 33, 34 . These morphological abnormalities accompany gene-expression pattern changes diagnostic for dorsalization: the positioning of the hindbrain marker krox20 reveals laterally expanded stripes when compared with controls, whereas, in the same embryos, expression of gata1, a marker of the ventrally specified erythroid lineage, is diminished (Fig. 4j-m) . Also in line with expansion of dorsal-cell fates, regional mRNA expression of the dorsally positioned Bmp antagonist chordin (Fig. 4n) is widened ventrally in shield-stage fcho1 morphants (Fig. 4o,p) . Reciprocally, the lateral bmp4 expression field is variably in the gastrula: proper locomotion of cells to the midline by modulating cell adhesion 39 . Administering full-length FCHO1 mRNA together with the fcho1 morpholino oligonucleotide increases morphologically normal 24 hpf embryos to 67% from 12% with the morpholino oligonucleotide alone (Fig. 4u-y) . There is more than 5 base pairs (bp) mismatch with the FCHO1 RNA (Supplementary Fig. S4 ), excluding the possibility that the co-injected transcript titrates out the fcho1 morpholino oligonucleotide. Injection of the µHD-encoding (1-610) transcript does not similarly correct development in fcho1 morphants, indicating that the basis for the dorsoventral patterning defect is Fcho1 insufficiency and that the intact protein is necessary for proper function (Fig. 4x,y) .
Because FCHO1 and FCHO2 are functionally redundant 12 , a translation-blocking fcho2 morpholino oligonucleotide was also analysed. The fcho2 morphants differ strikingly from those of fcho1, despite globally similar expression profiles during early embryogenesis ( Supplementary Fig. S5 ). The largely distinct developmental defects of the morphants indicate that Fcho1 and Fcho2 regulate separate events during zebrafish gastrulation and segmentation, but may also reflect temporal and regional differences in the expression of the two paralogues. There is evidence of weak overlapping function during embryogenesis: although fcho1/2 morpholino oligonucleotides combined do not provoke a gross phenotype distinct from fcho1 morpholino oligonucleotide alone, the krox20 lateral expansion, elliptical morphology and spectrum of dorsalized embryos is slightly more severe in fcho1/2 + p53-injected embryos than in fcho1+p53-treated ones ( Supplementary Fig. S5l-r) .
Fcho1 binds to Alk8
As the general fcho1 morpholino oligonucleotide phenotype mirrors Bmp antagonism, we investigated interaction between Fcho1 and Alk8, an early dorsoventral patterning type I receptor for Bmp2b-Bmp7 (refs 14,40,41) . A genetic link between fcho1 and alk8 is revealed by coinjection of morpholino oligonucleotides targeting the two transcripts at levels (0.5 ng) that, alone, do not produce many dorsalized embryos (Fig. 5a-e) . When combined, mildly dorsalized (C2) embryos result with defective ventral tail-fin development that resembles 5 ng alk8 morphants, suggesting that Alk8 and Fcho1 operate along the same pathway. This conclusion is directly substantiated biochemically. C-terminally Myc-tagged Alk8 in detergent lysates from transfected HeLa cells is bound by GST-FCHO1 µHD dose-dependently, along with the other binding partners (Fig. 5f-h) . Also, Alk8-Myc interacts with the immobilized cognate GST-Fcho1 µHDs (∼55% identical), whereas neither the Fcho2 (Fig. 5f ), FCHO2 nor SGIP1 µHD (Supplementary Fig. S6 ) bind similarly, despite equivalent eps15 interactions. The strong, differential interaction of the Fcho1/FCHO1 µHD with Alk8 is clearly consistent with the differing phenotypes in fcho1 or fcho2 morpholinoinjected embryos. There is no obvious preference of the Fcho1 µHD for binding to CA * Alk8 Q204D mutant 41 over the wild-type receptor (Fig. 5g) , whereas the related Alk1 interacts with the µHD comparatively weakly (Supplementary Fig. S6 ). The µHD interaction with Alk8 is similar to Hrb binding and both are displaced by the eps15(595-660) peptide at low concentrations (Fig. 5h) ; so Alk8 does not seem to use a tyrosine-based sorting signal to engage the Fcho1 µHD.
Injecting bmp2b + bmp7 mRNA elicits strong ventralization, although co-injection with fcho1/2 morpholino oligonucleotides results in genetic suppression, with primarily dorsalized embryos resulting (Fig. 6) . Ectopic mRNA encoding a phosphomimetic CA * Smad1 also strongly ventralizes, even in the presence of fcho1/2 morpholino oligonucleotides ( Fig. 6e-g ). These epistasis-type experiments place Fcho1 within a genetically specified sequence for Bmp signalling (Fig. 6n) . Overall, our data imply that Fcho1 positively regulates ventral specification during embryogenesis by bridging Alk8 and the clathrin machinery, consistent with expanded pSmad1/5/8 staining in FCHO1 mRNA-injected embryos.
AP-2 loss of function
FCHO1/2 are argued to be master actuators of endocytosis, remodelling the initial membrane patch and recruiting eps15 and intersectin before AP-2 (ref. 12). If FCHO1/2 are compulsory for clathrin-coated vesicle formation, one testable prediction is that the early dorsalizing effect of fcho1/2 morpholino oligonucleotides is wholly reflective of clathrin-mediated endocytosis dysfunction in developing embryos. Similarly to Fcho1/2, in D. rerio the AP-2 α subunit is encoded by a single gene (ap2a1) and is maternally deposited. The transcript is broadly expressed in blastula-, gastrula-and segmentation-stage embryos ( Supplementary Fig. S7a-c) , similarly to fcho1/2.
Translation-blocking ap2a1 morpholino oligonucleotide (Supplementary Fig. S4 ) produces pleomorphic early patterning and axis formation abnormalities and many embryos do not survive to 24 hpf (Fig. 7a-e, Supplementary Fig. S5 ). Phenotypes of surviving morphants at 24 hpf are classified from mild to arrested ( Supplementary Fig. S7d-i) . In the most severely affected embryos, the epiboly movement of blastomeres toward the vegetal pole slows and blastopore closure with incomplete epiboly results in dysmorphic bulging of the yolk (Fig. 7b,d ). This defect persists beyond bud stage (10 hpf) and yolk rupture typically follows 14-19 hpf (Fig. 7d) . Surviving arrested embryos are not developmentally delayed because there is no further morphological progression by 24 hpf (Supplementary Fig. S6h ). ap2a1 + p53 morpholino oligonucleotide-co-injected embryos still arrest, whereas simultaneous injection of the ap2a1 morpholino oligonucleotide and mouse Ap2a2 mRNA reverts the wild-type morphology (Fig. 7f) . A second ap2a1 and an AP-2 µ2-subunit-targeting morpholino oligonucleotide both cause an analogous phenotype. Epiboly arrest may be due, in part, to defective yolk-cell endocytosis as the blastoderm margin moves toward the vegetal pole 42 . Later, in surviving embryos, the ectoderm delaminates and the gross morphology is indicative of severe patterning defects (Fig. 7l, Supplementary Fig. S6f-h) , consistent with the severe effect of µ2 morpholino oligonucleotide in early Xenopus embryos 43 . A survey of standard target genes for early development 35 shows serious expression abnormalities. When gastrulation begins Fgf is normally produced from the dorsal organizer and weakly along the margin, but in ap2a1 (but not fcho1) morpholino oligonucleotide embryos fgf8 transcripts are expanded towards both the ventral and animal poles (Fig. 7g-i) . Improper fgf8 transcription is evident at 30% epiboly (∼4.7 hpf). At this stage, there is also precocious hyperactivation of the phosphatase Dusp6, an Fgf target gene 44 . Abnormal and mislocalized production of dusp6 in ap2a1 morphants persists to shield stage and, strikingly, expands far beyond the zone of fgf8 ligand expression. Co-injecting mRNA for AP-2 α subunit restores the normal dusp6 expression pattern (Fig. 7j) . Expansion of Fgf signalling range in AP-2-compromised embryos is consistent with endocytosis shaping and maintaining this morphogen gradient in the zebrafish gastrula 45, 46 . Clear Fgf signalling and phenotypic differences between ap2a1 and fcho1/2 + p53 morphants are apparent in live transgenic Tg(Dusp6:d2EGFP) pt6 reporter embryos 47 at the six-somite stage (Fig. 7k-m) . As the ap2a1 morpholino oligonucleotide embryos are still round, suppressing AP-2 expression must cause further cellular/regional defects because Fgf receptor hyperactivation typically induces dorsalization 44, 48 . Importantly, the GFP reporter rules out the possibility that abnormal activation of Fgf signalling underlies the fcho1 morpholino oligonucleotide dorsalization.
Other body-plan patterning pathways are anomalous in ap2a1-silenced embryos when gastrulation starts: distribution of chordin, bozozok, goosecoid and squint transcripts is abnormal (Fig. 7n-p) . Thus, AP-2 seems to function generally in multiple developmental pathways during early development, as seriously defective body-patterning information results without a functional adaptor. Because the effect on transducing Fgf and other inductive signals in ap2a1 morphants is distinct from how fcho1/2 morpholino oligonucleotides alter the fate map, we conclude that AP-2 function is not invariably dependent on upstream Fcho1/2 during embryogenesis.
DISCUSSION
Proper embryonic patterning depends on precise temporal integration of spatially complex signalling events. Endocytosis modulates signalling by constantly adjusting surface protein abundance 49 , and here we show that this process is vital for zebrafish development. Our results are consistent with Fcho1 operating with Alk8 and Bmp2b-Bmp7 heterodimers to signal ventral fates. Because FCHO1/2 are incontestably clathrin-coat constituents, the simplest model is that clathrin-mediated endocytosis promotes Bmp signalling. The precise basis for this remains to be elucidated; one possibility is that Fcho1/2 with Alk8 shapes the ventral Bmp gradient, as does type I BMP receptor Thick veins in Drosophila 50 . Thick veins, the Drosophila Decapentaplegic receptor, binds directly to another intersectin-binding EFC-domain protein, Nervous wreck 51 . Yet Nervous wreck has a C-terminal SH3 domain substituted for the µHD, so the basis for the interaction cannot be structurally similar, and, critically, the consequence of the association is negative feedback on Decapentaplegic signalling. It thus seems remote that muniscins govern routing of Alk8 receptors to lysosomes, because Fcho1 positively modulates Bmp signalling in zebrafish embryos.
Receptors can require previous internalization and recycling to gain signalling competence 52 . Another possibility then is that, by promoting uptake of uncomplexed type I receptors (Alk8), the level of type I-II functional heterodimers is optimized. Alternatively, Fcho1 could be involved in forming Bmp gradients by decreasing available receptor/ligand in dorsally positioned cells, but that would give rise to ventralization, not dorsalization, on morpholino oligonucleotide injection. More likely, clathrin-mediated endocytosis provides access to an endosomal signalling station for cytosolic propagation and refinement of the Bmp signal. Spatial separation between TGF-β/BMP receptor activation at the plasma membrane and signal propagation from endosomes is apparent 53, 54 . In cultured cells, the extent of activin-triggered Smad phosphorylation decreases when internalization is blocked 55 . Optimal phosphorylation of R-Smads by TGF-β receptors requires SARA, an endosome-associated PtdIns3P-binding protein [56] [57] [58] [59] . The R-Smad-binding FYVE-domain protein Endofin plays an analogous role during BMP signalling 60 . Fcho1 could then drive the delivery of Alk8 to endosomes for an encounter with Endofin.
Zebrafish are characterized by very rapid developmental progression; tissue-specific cell clones are evident during gastrulation (>6 hpf) and a recognizable body plan and differentiating organs apparent before 12 hpf (ref. 61) . Perhaps Fcho1/2 has been previously missed because the time constraints for signal propagation in other systems are dissimilar to D. rerio early development. An association between FCHO1 and ACVR1, the mammalian Alk8 orthologue, has been mapped by high-throughput affinity-capture proteomics 62 . Another hallmark of zebrafish embryogenesis is brisk and expansive cell movements. Maximal signal transmission from an endosomal extension of the cell surface may enable proper 'memory' signalling in cells that have moved away from the initial, fate-determining morphogen gradient 63 . On the basis of morpholino oligonucleotides recapitulating maternaleffect phenotypes 33 , it is clear that the translational-silencing approach ablates maternal-gene expression. Why then are fcho1, fcho2 and ap2a1 morphants not more severely affected? Targeted gene disruption of the AP-2 µ2 subunit is lethal 64 , but ap2a1 morpholino oligonucleotide in zebrafish enables visualization of early embryonic processes before dysmorphic arrest due to protein insufficiency. This is because morpholino oligonucleotide-based silencing cannot obstruct maternally deposited protein. Substantial clathrin-coat machinery must be provisioned in the oocyte, as massive cortical granule exocytosis following fertilization is balanced by compensatory clathrin-dependent endocytosis 65 . Clathrin-coated buds are also seen at the cleavage furrow during the initial rounds of cell division following fertilization 66 . Still, an early and severe developmental defect on ap2a1 silencing is fully consistent with AP-2 µ2-subunit morphants in Xenopus 43 . Strikingly, the phenotypic outcomes of extinguishing AP-2 or Fcho1/2 transcripts are not identical. If Fcho1/2 are obligatory for the nucleation of endocytic clathrin coats, this is unexpected. One possibility is that the perdurance of the muniscins is greater than that of the AP-2 heterotetramer in early embryos. However, simultaneous RNA interference silencing of both FCHO1 and FCHO2 in either HeLa or BS-C-1 cells does not cause loss of AP-2-positive clathrin-coated structures at the cell surface (Fig. 8) . This is fully consistent with the very mild phenotype in syp1 yeast 15, 17, 18 . The structure, dynamics 7, 12, 67 and extensive interactions shared by FCHO1 and FCHO2 suggest that muniscins advance clathrin endocytosis. This may explain the weak additive effect of fcho2 morpholino oligonucleotide on the fcho1 morphant phenotype, reflecting a degree of functional overlap between the paralogues. If part of a pioneer module 7, 12 , how do clathrin coats persist without these factors? A topological feature of the clathrin interactome is redundancy 2, 6 . Surplus connections make the network tolerant to perturbations; AP-2 can be largely extinguished in cultured cells but rapid uptake of certain cargo continues 27, 28 . As the µHD engages other pioneer scaffolds (Fig. 2h) , collective establishment of this preponderance of links, even without Fcho1/2, permits positioning of AP-2 at the first encounter zone of a bud site. Cargo-selective defects are instead manifest, highlighting that all known µHD-bearing proteins are involved in gathering cargo 15 .
METHODS
Methods and any associated references are available in the online version of the paper at www.nature.com/naturecellbiology and zebrafish fcho2 were similarly cloned into pCS2 + for mRNA synthesis or transient transfections. Stop codons were introduced at appropriate sites using QuikChange (Stratagene) site-directed mutagenesis to construct FCHO1(1-275), FCHO1(1-609), Fcho2(1-302) and the various other truncation mutants described in the text. The GST-β2 appendage (rat residues 701-937), GST-α C appendage (mouse residues 701-938), GST-eps15(595-896) and GST-ARH constructs have been described previously 15, 25, 68 . The 25-bp regions at the 5 end of zebrafish fcho1, fcho2 and ap2a1 used to design antisense morpholinos were cloned in-frame into pCS2-GFP-N1 to generate respective 5 -morpholino oligonucleotide-GFP constructs that were subsequently used to test the effectiveness of translational silencing by fcho1, fcho2 and ap2a1 morpholino oligonucleotides in vivo. The coding sequence of the zebrafish fcho1 µHD with flanking 5 and 3 regions was first amplified by RT-PCR from 1,000-cell-stage zebrafish embryonic cDNA using a set of PCR primers designed from EST clones encoding the 5 (GenBank accession AL920021) or the 3 (GenBank AL921007) ends of the µHD. Then, the complete coding sequence of the µHD was PCR amplified from the RT-PCR product and cloned into pGEX-4T-1. The pCS2-alk8, pCS2-bmp2b and pCS2-bmp7 plasmids 13 were provided by M. Mullins whereas the pCS2-CA * smad1 construct ( 470 SVS of zebrafish Smad1 mutated to 470 DVD) was a gift from B. Roman. The alk8 coding sequence was PCR amplified from pCS2-alk8 and subcloned into the pCS2-Myc 6 vector to obtain pCS2-alk8-Myc 6 . A Q204D mutation yielded the CA * Alk8. All constructs were sequence-verified and full details of plasmids and primers (Integrated DNA Technologies) are available on request.
RT-PCR and 5 rapid amplification of cDNA ends (RACE). Total RNA (5 µg)
extracted from embryos at different developmental stages using the TRIZOL method (Invitrogen) was used as template for cDNA preparation. cDNA was generated using an oligo-(dT) primer and Thermoscript reverse transcriptase (Invitrogen) according to the manufacturer's directions. Subsequently, the cDNA was amplified with gene-specific primers for fcho1, fcho2 and ap2a1 (as listed in Supplementary Table) . β-actin primers were used as an internal control for the quality of cDNA synthesis. The amplified DNA was subjected to agarose gel electrophoresis and exon-specific bands identified both by size and by sequencing. 5 RACE was carried out by standard procedures (Invitrogen). Total RNA from one-cell-and 1,000-cell-stage embryos was reverse transcribed to cDNA using an antisense gene-specific primer (GSP1) near the 5 end. The template cDNA was tailed at the 3 end using dCTP and terminal deoxynucleotidyl transferase (New England Biolabs). The tailed cDNA was PCR amplified with a set composed of a 5 RACE anchor adaptor primer and a second antisense gene-specific primer (GSP2). The primer sequences used for 5 RACE are provided in Supplementary Table. The amplicon was purified, confirmed by sequencing and the sequence deposited in GenBank (accession number JN412732) at the National Center for Biotechnology Information.
Antibodies. The affinity-purified rabbit anti-FCHO1 antibody 1 (1:2,500), anti-FCHO2 (1:2,500), anti-Dab2 (1:1,000), anti-epsin 1 (1:10,000) and anti-AP-1/2 β1/β2-subunit GD/1 (1:2,500) antibodies were produced commercially for our laboratory. A second affinity-purified anti-FCHO2 (1:2,500) antibody was provided by H. McMahon. Affinity-purified rabbit anti-eps15 polyclonal antibody was a gift from E. Ungewickell, the anti-clathrin heavy chain mAbs TD.1 (1:5,000) and X22 and the anti-AP-2 α-subunit mAb AP.6 were provided by F. Brodsky, the anti-CALM mAb (1:1,000) provided by J-A. Kim, rabbit R11-29 anti-AP-2 µ2-subunit (1:3,000) antiserum provided by J. Bonifacino and the rabbit anti-intersectin 1 (1:2,000) antibody a gift from P. McPherson. The affinity-purified rabbit anti-APPL1 (1:50) was provided by D. Kaplan. Goat anti-Hrb C-19 (1:1,000; sc-1424) and rabbit anti-eps15 C-20 (1:500; sc-534) polyclonal antibodies and rabbit anti-SHIP2 mAb E-2 (1:500; sc-166641) from Santa Cruz Biotechnology, rabbit anti-eps15R (1:5,000; EP-1145Y) antibody and rabbit anti-FCHO1 antibody 2 (1:1,000; ab84740) from Abcam, and mouse anti-Myc mAb 9E10 (1:1,000; MMS-150P) from Covance were used. The anti-β-tubulin mAb E7 (1:2,500) was purchased from the Developmental Studies Hybridoma Bank; mAbs directed against the AP-2 α subunit clone 8/Adaptin α (1:1,000; 610502), AP180 clone 34 (1:250; A41820), amphiphysin I clone 15 (1:5,000; A59420), EEA1 clone C14/EEA1 (1:250; 610457) and intersectin clone 29 (1:250; 611574) were from BD Transduction Laboratories. The secondary antibodies used were donkey anti-rabbit (1:5,000; NA934V) or anti-mouse (1:5,000; NA931V) horseradish peroxidase conjugates from GE Healthcare or rabbit anti-goat (1:5,000; A4174) peroxidase conjugate from Sigma.
Cell culture and transfections. HeLa SS6 cells were cultured in DMEM supplemented with 10% fetal calf serum and 2 mM l-glutamine at 37 • C in an atmosphere of 5% CO 2 . BS-C-1 cells stably expressing GFP-tagged clathrin light chain a were provided by T. Kirchhausen. The BS-C-1 cells were similarly grown in DMEM, 10% fetal calf serum, 2 mM l-glutamine, supplemented with 0.4 mg ml −1 G418. Cells were routinely transfected with plasmids using Lipofectamine 2000 (Invitrogen) or siRNA oligonucleotides (listed in Supplementary Table) using Oligofectamine (Invitrogen) according to the manufacturer's instructions. For all RNA interference treatments, cells were transfected twice, normally 48 h apart and reseeding the cells before the second siRNA application, at which time the relevant transiently transfected plasmid was also included. Typically, 18-24 h after the second transfection, cells were fixed with 4% paraformaldehyde, blocked and permeabilized in 10% normal goat serum, 0.2% saponin, in PBS. For transferrin binding and uptake assays, cells were incubated in DMEM, 25 mM HEPES, 0.5% BSA, for 1 h at 37 • C to remove bound transferrin. Alternatively, lysates from parental HeLa cells or HeLa cells expressing (from pCS2 + ) full-length 61 . The sequences of the various morpholinos used in this study, custom synthesized by Gene Tools, are listed in Supplementary Table. The translationblocking ATG-specific fcho1 morpholino was designed on the basis of the authentic 5 sequence of zebrafish embryonic fcho1 transcript mapped by 5 RACE. A standard control morpholino oligonucleotide and a p53 morpholino oligonucleotide were obtained from Gene Tools as detailed elsewhere 69 . The desired concentrations of the appropriate morpholinos were microinjected at 5 nl per embryo into the yolk at one-to two-cell stage. Capped mRNAs for misexpression and rescue experiments were transcribed in vitro from linearized pCS2 + constructs using an SP6 mMessage mMachine kit (Ambion) and microinjected at 1 nl into the blastomere at the one-cell stage. After injections, the embryos were incubated in E3 medium (5 mM NaCl, 0.17 mM KCl, 0.33 mM CaCl 2 , 0.33 mM MgSO 4 , 0.01% methylene blue) at 28 • C until the desired stage.
Whole-mount in situ hybridization and immunofluorescence. The EST clones for fcho1 (GenBank AL920021) and ap2a1 (GenBank AL920300) in pBluescript SK + were obtained from Open Biosystems, linearized and directly used for riboprobe synthesis. For fcho2, an 880-bp fragment encoding the C-terminal end was PCR amplified (using fcho2 T7 sense and antisense primers) from the zebrafish fcho2 EST clone (GenBank BC095680). All other probes used in this study (no tail, sonic hedgehog, bmp4, chordin, krox20, gata1, goosecoid, bozozok, squint, fgf8, fgfR1 and dusp6 ) were made similarly by linearizing corresponding vectors containing a T7 RNA polymerase promoter, using appropriate restriction enzymes as described elsewhere 47, 69 . Riboprobe synthesis for in situ hybridization was carried out using digoxigenin RNA labelling mix and T7 RNA polymerase (Roche) according to the manufacturer's recommendations. Zebrafish embryos at appropriate developmental stages were fixed in 4% paraformaldehyde at 4 • C overnight, washed once in PBS and stored in methanol at −20 • C. Whole-mount in situ hybridizations were carried out by standard procedures 69 . Embryos were washed several times in PBS and mounted in glycerol. Alternatively, live embryos, either within or removed from the chorion, were mounted in 3% methylcellulose and overlaid with E3 containing 0.016% tricaine (pH 7.0). Oriented embryos were viewed using a Leica MZ16FA stereo fluorescence microscope with a ×1 (numerical aperture 0.14) objective and bright-field or fluorescence images collected with a QImaging Retiga-EXi Fast 1394 digital camera.
For immunofluorescence, embryos fixed overnight in 4% paraformaldehyde at 4 • C were permeabilized in 1% Triton X-100, blocked in 10% sheep serum, 1% DMSO, 0.1% Triton X-100, in PBS and probed overnight with rabbit anti-pSmad 1/5/8 (1:100; 9511) from Cell Signaling Technology or GD/1 (1:100) antibody. The immunizing peptide for the GD/1 antibody (GDLLNLLGPPV) is 100% conserved in the D. rerio AP-2 β2 subunit (ap2b1). Primary antibodies were followed with goat anti-rabbit Alexa 488-or Cy5-conjugated antibody (1:500; Molecular Probes) and Hoechst 33258 nuclear stain before mounting for confocal microscopy.
For GFP-FCHO1/AP-2 immunofluorescence, embryos at 5 hpf were embedded in 1% low-melting-point agarose in E3 medium on poly-d-lysine-coated dishes (MatTek) with the animal pole oriented toward the glass bottom. For pSmad 1/5/8 immunofluorescence, embryos at 7 hpf were embedded with dorsal shield side toward the right. Images were acquired on an Olympus Fluoview1000 confocal microscope using a UPlanSApo ×20 (numerical aperture 0.75) or a UPlanFLN ×40 (numerical aperture 1.3) oil objective. Data were acquired using the FV10-ASW software. Similar procedures were used for immunofluorescence analysis of cultured mammalian cells. 
